Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1697-2020Class II

Nitinol Thermocouple Electrode, 15 cm, 3m Cable -

Boston Scientific Neuromodulation Corporation / initiated 2019-05-30 / Terminated / root cause: labeling and UDI

Boston Scientific Neuromodulation Corporation began a recall of Nitinol Thermocouple Electrode, 15 cm, 3m Cable - Product Usage: The TCN Electrode is indicated for use in RF heat lesioning of peripheral nerve tissue... on . FDA classified it as Class II and gives the reason as "The firm initiated a voluntary correction of certain Cosman TCN Electrodes due to an incorrect revision of the Instructions for Use (IFU) being packaged with these products". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1697-2020
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Boston Scientific Neuromodulation Corporation
Product
Nitinol Thermocouple Electrode, 15 cm, 3m Cable - Product Usage: The TCN Electrode is indicated for use in RF heat lesioning of peripheral nerve tissue only.The Cosman Medical TCN Electrodes are temperature-sensing probes for use in the percutaneous treatment of pain.
Product code
GXI Probe, Radiofrequency Lesion
Reason for recall
The firm initiated a voluntary correction of certain Cosman TCN Electrodes due to an incorrect revision of the Instructions for Use (IFU) being packaged with these products.
Root cause tag
labeling and UDI
FDA root cause
Error in labeling
Action
The firm reported that they have included replacement IFUs with the notification package and these were sent Fedex 2 Day mail. The following was included in the firm's notification letter: "Your local Sales Representative can answer any questions that you may have regarding this correction. Please pass this notice to any healthcare professional from your organization who needs to be aware and to any organization where the potentially affected devices have been transferred (if appropriate). Please provide details of any affected devices that have been transferred to other organizations (if appropriate). The Reply Verification Tracking Form enclosed with the Notice must be completed and returned even if you do not have any affected units in your inventory. 1.Complete and return the Reply Verification Tracking Form (RVTF). Complete the enclosed Reply Verification Tracking Form even if you do not have any affected product to be corrected. Follow the directions on this page and on the Reply Verification Tracking Form. Verify if the product within your inventory is affected. If so, indicate on your Verification Form the part and lot number(s) in your possession. Email or fax the Reply Verification Tracking Form to the Field Action Center as described below: Email: [email protected] or Fax to: Field Action Center 1-866-213-1806 Please email or fax your Reply Verification Tracking Form(s) immediately. 2. Place the included replacement IFUs with any affected product you have identified in your inventory. IFUs originally included with affected products must be discarded."
Quantity in commerce
40 units
Distribution
US Nationwide distribution in the states of AZ, CA,CO, FL,GA, ID,IL, IN, KY, MA, MD, MI, MO, NV, NY, OH, OK, OR, SC, TX, UT, VA, WA, and WI.
Product codes and lots
TCN-15-3M; GTIN: 00813250017519; Lot Number:23049684

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1697-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1694-2020Class IITerminatedVoluntary: Firm initiated
Z-1695-2020Class IITerminatedVoluntary: Firm initiated
Z-1696-2020Class IITerminatedVoluntary: Firm initiated
Z-1697-2020Class IITerminatedVoluntary: Firm initiated
Z-1698-2020Class IITerminatedVoluntary: Firm initiated